Loading university
P Jeffrey Conn — Dr. P Jeffrey Conn's lab at Vanderbilt University focuses on understanding how two specific proteins in the brain, mGlu3 and mGlu5, work together to improve learning and memory. By studying these interactions in rodent models, the lab aims to find new ways to enhance cognitive function and address cognitive deficits related to disorders like schizophrenia. Their research combines advanced techniques in genetics, pharmacology, and neurobiology to explore new treatments for these challenges.
Bingshan Li — Bingshan Li's lab at Vanderbilt University focuses on understanding how different types of brain cells communicate and interact during the progression of Alzheimer's disease (AD). By employing advanced computational techniques and human-derived brain models, the lab aims to uncover the complex cellular mechanisms that contribute to memory loss and cognitive decline in AD patients. This research provides insights that could help in developing new therapeutic strategies for this devastating disorder.
Antonis Rokas — Dr. Antonis Rokas' lab at Vanderbilt University focuses on understanding why some species of the Aspergillus fungus cause disease while closely related species do not. They explore the genetic traits that contribute to the pathogenicity of Aspergillus fumigatus, a major human pathogen, by examining both the environmental and biological factors that influence fungal virulence. This research aims to shed light on the evolution of fungal pathogens and improve strategies for combating infections.
Lisa M Monteggia — Dr. Lisa Monteggia's research lab at Vanderbilt University focuses on understanding the molecular mechanisms behind rapid and sustained antidepressant effects, particularly those induced by the drug ketamine. The lab investigates how brain-derived neurotrophic factor (BDNF) and methyl-CpG binding protein 2 (MeCP2) contribute to these antidepressant actions at the synaptic level. This research aims to uncover new treatment strategies for depression that could lead to faster and more effective therapies.
Vsevolod V. Gurevich — Dr. Vsevolod V. Gurevich's lab focuses on understanding the molecular interactions of a protein called arrestin-1 with rhodopsin, which is crucial for vision. Researchers in this lab study how different forms of rhodopsin affect arrestin-1 binding and explore ways to create modified versions of arrestin-1 that could help treat vision disorders related to defects in rhodopsin phosphorylation. The work involves a mix of molecular biology techniques and innovative labeling methods to discover new proteins that interact with arrestin-1.
Neil Osheroff — Dr. Neil Osheroff's lab at Vanderbilt University focuses on understanding how certain antibiotics work and how bacteria resist them. The lab studies key bacterial enzymes that are targets for widely used antibacterial drugs like fluoroquinolones. By investigating these enzymes and their interactions with both existing and novel antibiotics, the team aims to develop new strategies to combat antibiotic-resistant bacterial infections.
Adam W Anderson — Dr. Adam W. Anderson’s lab at Vanderbilt University focuses on improving the technology and methods used in diffusion MRI to better visualize and understand brain structures. By developing advanced techniques for analyzing MRI data, the lab works to enhance the sensitivity and accuracy of brain imaging, which is vital for diagnosing and monitoring brain disorders. Their research not only aims to refine these imaging techniques but also strives to link MRI findings with the underlying biophysical properties of brain tissues, which will ultimately aid in patient care.
Sohee Park — Dr. Sohee Park's lab focuses on understanding the relationship between self-perception and social interactions in individuals with schizophrenia. Using innovative methods like virtual reality, the lab investigates how disruptions in the sense of self contribute to social impairments. The goal is to uncover the mechanisms behind these issues to develop better treatment strategies for improving social functioning in those affected by schizophrenia and related disorders.
Thilo Womelsdorf — Dr. Thilo Womelsdorf's lab at Vanderbilt University studies how certain drugs can improve cognitive abilities and motivation. They specifically focus on a new type of drug designed to work with receptors in the brain that influence behavior and thought processes, particularly concerning conditions like schizophrenia. The research involves both behavioral tests on primates and measurements of brain chemistry to understand how these drugs can help enhance mental functions without unpleasant side effects.